Schultes Birgit C

3.2

3.2

• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings

Download results Settings

Intellia Therapeutics Inc (NTLA)

Transaction date 5 Jan 2026

Planned sale

Price

163.74

Quantity 24,719 +40.2%

Value US$628,178

Comments Filing

Intellia Therapeutics Inc (NTLA)

Transaction date 1 Oct 2025

Sale

Price

266.01

Quantity 89,520 +47.9%

Value US$4,765,379

Comments Filing

Notification date	Transaction date	Company	B/S Transaction type	Nb. shares Price Value	Number of shares	Price	Value	Details
2026-01-07	2026-01-05	Intellia Therapeutics Inc (NTLA)	PlS Planned sale	24,719 +40.2% 163.74 US$628,178	24,719 +40.2%	163.74	US$628,178
2025-10-03	2025-10-01	Intellia Therapeutics Inc (NTLA)	S Sale	89,520 +47.9% 266.01 US$4,765,379	89,520 +47.9%	266.01	US$4,765,379